Skip to main content

Cochlear Implant

0
Pipeline Programs
4
Companies
5
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Advanced Bionics
Advanced BionicsCA - Valencia
2 programs
Fitting strategy of cohlear implant of hearing aidN/A1 trial
Naida Hearing AidN/A1 trial
Active Trials
NCT04222296Completed30Est. Mar 2021
NCT04155138Unknown15Est. Mar 2021
Cochlear
CochlearAustralia - Macquarie Park
1 program
OMRP R2 + Percepolis Accessory SoftwareN/A1 trial
Active Trials
NCT07033130Recruiting20Est. Jun 2026
Oticon
OticonDenmark - Smørum
1 program
cochlear implantationN/A1 trial
Active Trials
NCT02966379Completed17Est. Oct 2018
iotaMotion
iotaMotionIA - Iowa City
1 program
iotaSOFT Insertion SystemN/A1 trial
Active Trials
NCT04577118Completed25Est. Apr 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
CochlearOMRP R2 + Percepolis Accessory Software
iotaMotioniotaSOFT Insertion System
Advanced BionicsNaida Hearing Aid
Advanced BionicsFitting strategy of cohlear implant of hearing aid
Oticoncochlear implantation

Clinical Trials (5)

Total enrollment: 107 patients across 5 trials

NCT07033130CochlearOMRP R2 + Percepolis Accessory Software

The Performance of Different Sound Paths in Adult NeuroZti CI-users

Start: Feb 2026Est. completion: Jun 202620 patients
N/ARecruiting
NCT04577118iotaMotioniotaSOFT Insertion System

The iotaSOFT Insertion System Safety Study

Start: Sep 2020Est. completion: Apr 202125 patients
N/ACompleted
NCT04155138Advanced BionicsNaida Hearing Aid

Recipients With Limited Bimodal Benefit: HA or CROS

Start: Dec 2019Est. completion: Mar 202115 patients
N/AUnknown
NCT04222296Advanced BionicsFitting strategy of cohlear implant of hearing aid

Bimodal, CROS and Severe Profound Hearing Loss Study

Start: Sep 2018Est. completion: Mar 202130 patients
N/ACompleted
NCT02966379Oticoncochlear implantation

Hearing Preservation and Electro-acoustic Stimulation With EVO® Electrode Lead and Zebra® Sound Processor

Start: Mar 2016Est. completion: Oct 201817 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 107 patients
4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.